Category: Research

This content is visible only to logged in members with an active membership.

If you are a member, please log in to your account.

Log in to your SHFNF account

http://www.nejm.org/doi/full/10.1056/NEJMoa1506459

Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure

Authors: Clark AL, Johnson M, Fairhurst C, Torgerson D, Cockayne S, Rodgers S, Griffin S, Allgar V, Jones L, Nabb S, Harvey I, Squire I, Murphy J, Greenstone M

Journal: Health Technology Assessment Volume: 19 Issue: 75

Publication date: September 2015

DOI: http://dx.doi.org/10.3310/hta19750

Citation:

Clark AL, Johnson M, Fairhurst C, Torgerson D, Cockayne S, Rodgers S, et al.Does home oxygen therapy (HOT) in addition to standard care reduce disease severity and improve symptoms in people with chronic heart failure? A randomised trial of home oxygen therapy for patients with chronic heart failure. Health Technol Assess 2015;19(75)

Download: Citation (for this publication as a .ris file) (688 Bytes)

Trial: SUPPORT HF-2 (Seamless User-centred Proactive Provision Of Risk-stratified Treatment for Heart Failure)
Details: A study of home monitoring for the management of heart failure with integrated data analysis and risk stratification tools providing alerts to patients and health care practitioners. More information.
See the trial website. Interest from new sites is welcome. Please get in touch with the Trial Manager if you are interested in participating or would like more information
Investigator: Professor Kazem Rahimi, The George Institute for Global Health, University of Oxford (kazem.rahimi@georgeinstitute.ox.ac.uk)
Trial Manager: Denise Fleming-Brown, The George Institute for Global Health, University of Oxford (denise.fleming-brown@georgeinstitute.ox.ac.uk)

Trial: INOVATE-HF
Details: study of vagal stimulation in patients with severe heart failure in addition to best medical therapy. An implantable device deliver electrical stimulation to the vagus nerve in the neck. No new centres required however trialists keen to develop referral networks
Investigator: Rami Biran (rami@biocontrol-medical.com)

Now recruiting

Trial: IRON-MAN
Details: Iron replacement therapy in heart failure
Contact: Paul Kalra (paulkalra@doctors.org.uk)